Cargando…
Improving Generation of Cardiac Organoids from Human Pluripotent Stem Cells Using the Aurora Kinase Inhibitor ZM447439
Drug-induced cardiotoxicity reduces the success rates of drug development. Thus, the limitations of current evaluation methods must be addressed. Human cardiac organoids (hCOs) derived from induced pluripotent stem cells (hiPSCs) are useful as an advanced drug-testing model; they demonstrate similar...
Autores principales: | Lee, Su-Jin, Kim, Hyeon-A, Kim, Sung-Joon, Lee, Hyang-Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698385/ https://www.ncbi.nlm.nih.gov/pubmed/34944767 http://dx.doi.org/10.3390/biomedicines9121952 |
Ejemplares similares
-
Antitumor profiles and cardiac electrophysiological effects of aurora kinase inhibitor ZM447439
por: Lee, Hyang-Ae, et al.
Publicado: (2019) -
Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015) -
The Aurora Kinase Inhibitor CYC116 Promotes the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
por: Ji, Sijia, et al.
Publicado: (2022) -
Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012) -
Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)